跳至主要内容
临床试验/SLCTR/2023/018
SLCTR/2023/018尚未招募3 期

Ferrous ascorbate versus ferrous sulfate and ferrous fumarate in women with iron-deficiency anemia in pregnancy: a multi-centre randomized controlled trial

Zydus Lifesciences Ltd.0 个研究点目标入组 396 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
396

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Pregnant female (gestational age 14 to 24 weeks).
  • 2.Aged 18 years and above.
  • 3.Hemoglobin levels <11 g/dl but >7 g/dl and serum ferritin < 30 µg/dl.
  • 4.A diagnosis of iron deficiency anaemia based on the blood picture.

排除标准

  • 1.Hypersensitivity to iron supplements
  • 2.Reported intolerance to iron supplements in the past
  • 3.Severe anemia requiring parentral transfusion or transfusion of blood products
  • 4.Known diagnosis of anemia related to causes other than iron deficiency (thalassemia, chronic disease, sickle cell, sideroblastic anaemia etc.)
  • 5.Hemochromatosis or iron overload
  • 6.Malabsorptive, ulcerative or inflammatory gastro-intestinal disease
  • 7.History of serious progressive or chronic inflammatory disease (cardiac, renal, hepatic, oncological, autoimmune or any other systemic disease)
  • 8.Undergone surgery in one month before enrolment or planned to undergo surgery during the course of study
  • 9.Subject simultaneously participating in any other clinical studies or having participated in any other clinical trial in the past 3 months.
  • 10.History or other evidence of severe illness or any other conditions that would make the patient, in the opinion of the investigator, unsuitable for the study (such as poorly controlled psychiatric disease, bariatric or bowel surgery, HIV infection, or severe coronary artery disease).

研究者

发起方
Zydus Lifesciences Ltd.

相似试验

Efficacy of ferrous ascorbate versus ferrous sulfate... | 临床试验